COL4A4 Gene Alport Syndrome (Autosomal Recessive) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين COL4A4 لمتلازمة ألبورت (متنحية صبغية جسدية) بتقنية التسلسل الجيني المتقدم (NGS) في الإمارات | 2800 درهم | إرشادات هيئة الصحة بدبي 2026

ملخص تنفيذي: تحليل جيني فائق الدقة بنسبة حساسية تشخيصية 99.9%، مع خدمة سحب دم منزلي متميزة وفق معايير الآيزو.

✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
✓Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection.
✓Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
✓Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Overview

The COL4A4 Gene Alport Syndrome (Autosomal Recessive) NGS Test identifies pathogenic variants in the COL4A4 gene that cause autosomal recessive Alport syndrome—a progressive kidney disease with hearing and vision involvement. هذا التحليل الجيني يكتشف الطفرات المسببة لمتلازمة ألبورت المتنحية الصبغية الجسدية. Our test delivers clinical-grade precision using full-gene sequencing, supportive pre-test counselling, and UAE‑compliant reporting.

Feature	Our Test (COL4A4 NGS)	Closest Alternative (Sanger Sequencing)
Precision / Coverage	Full gene sequencing – all exons and splice sites	Single‑exon or targeted mutation analysis only
Methodology	Next Generation Sequencing (Illumina NovaSeq)	Sanger sequencing
Turnaround Time	3 to 4 Weeks	6 to 8 Weeks
UAE Regulatory Compliance	Full – ISO 9001:2015, PDPL	Variable

Physician Insight & Safety Protocol

“As a DHA‑licensed clinical pathologist, I emphasize that a positive COL4A4 mutation cannot be interpreted in isolation; clinical correlation with renal function, audiometry, and family history is essential. Genetic results alone do not replace the need for lifelong nephrology follow‑up. Kindly reach out for a post‑test consultation to ensure clarity.” — Dr. PRABHAKAR REDDY (DHA: 61713011)

⚠ Medication Warning: Do not discontinue prescribed medication without consulting your doctor. This test provides genetic information only and does not alter acute treatment protocols.

Exclusion Criteria & Emergency Red Flags

Testing of minors without parental/legal guardian consent (in accordance with UAE CDS Law 2026).
Asymptomatic individuals without a confirmed family history or a prior genetic counselling session.
This test is not a substitute for renal biopsy, ophthalmologic examination, or audiological assessment.

ER Red Flags – seek immediate medical attention if the patient experiences:

Sudden hearing loss or tinnitus.
Oliguria (low urine output) or anuria.
Severe flank pain with fever.
Rapid weight gain from edema.

Patient FAQ & Clinical Guidance

1. What is the COL4A4 gene Alport syndrome test, and how does it help?

This NGS test identifies genetic variants in COL4A4 responsible for autosomal recessive Alport syndrome affecting the kidneys, ears, and eyes. It confirms the diagnosis at a molecular level, aids in family risk assessment, and guides monitoring for extra‑renal complications. هذا الفحص الجيني يُحدد الطفرات في جين COL4A4 المسبب لمتلازمة ألبورت المتنحية

2. Who should consider this test in the UAE?

Individuals with unexplained hematuria, hearing loss, or family history of Alport syndrome require genetic confirmation for optimal management. The test is equally indicated for potential carriers in consanguineous families, a common presentation in the region. الأشخاص الذين يعانون من دم في البول دون تفسير أو فقدان سمع أو تاريخ عائلي للمتلازمة

3. How accurate is the test and what does it cost?

Our NGS offers >99.9% analytical sensitivity and specificity at 2800 AED with home collection and 3‑4 week TAT. The price covers the full gene sequencing, genetic counselling online session, and a detailed clinical report aligned with 2026 DHA standards. دقة التحليل تتجاوز 99.9% وسعره 2800 درهم شامل الاستشارة الوراثية والتقرير الطبي المعتمد

دعم ثنائي اللغة متاح